San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast cancer, including novel treatments, new treatment regimens and more.See Healio’s highlights in H ...
18h
GlobalData on MSNPhoenix Molecular kicks off Phase II part of breast cancer combo trialThe Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...
EXCLUSIVE: Traitors star Leanne Quigley has opened up about the heartbreaking breast cancer battle her fiancee Sophie Jones ...
The Traitors winner Leanne Quigley opens up movingly on the most traumatic two years of her life - as she admits her and ...
Tempus AI (TEM) and Stemline Therapeutics, a wholly-owned subsidiary of the Menarini Group, announced a new collaboration. The two companies ...
Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...
As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.
Cervical cancer is a major health issue for Indian women, primarily caused by HPV. Key symptoms include abnormal bleeding and ...
In a previous trial, patients with RSK2-high cancers had a significantly greater benefit from treatment with PMD-026 than those with RSK2-low cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results